(Q43828966)

English

Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells

scientific article published in February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ramesh K Sood

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Vishweshwar S Bhadti

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ali I Fattom

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Robert B Naso

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Brent E Korba

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Earl R Kern

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Huan-Ming Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Ramachandra S Hosmane

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

159-164

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

An efficient, short synthesis and potent anti-hepatitis B viral activity of a novel ring-expanded purine nucleoside analogue containing a 5:7-fused, planar, aromatic, imidazo[4,5-e][1,3]diazepine ring system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of selected antiviral compounds on human hepatitis B virus DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of replication of hepatitis B virus by cytallene in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900204-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0166-3542(01)00204-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43828966&oldid=2103707411"